Skip to main content
. 2024 Mar 7;13:e50513. doi: 10.2196/50513

Table 1.

Dose-escalation or de-escalation rule for the Bayesian optimal interval design.

Actions The number of patients treated at the current dose

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Escalate if the number of DLTa is ≤ 0 0 0 0 1 1 1 1 2 2 2 2 3 3 3
De-escalate if the number of DLT is ≥ 1 1 2 2 2 3 3 3 4 4 4 5 5 6 6
Eliminate if the number of DLT is ≥ N/Ab N/A 3 3 4 4 5 5 5 6 6 7 7 8 8

aDLT: dose-limiting toxicity.

bN/A: not applicable.